JP2009502922A5 - - Google Patents

Download PDF

Info

Publication number
JP2009502922A5
JP2009502922A5 JP2008523976A JP2008523976A JP2009502922A5 JP 2009502922 A5 JP2009502922 A5 JP 2009502922A5 JP 2008523976 A JP2008523976 A JP 2008523976A JP 2008523976 A JP2008523976 A JP 2008523976A JP 2009502922 A5 JP2009502922 A5 JP 2009502922A5
Authority
JP
Japan
Prior art keywords
alkyl
membered
disease
aryl
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008523976A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009502922A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/028174 external-priority patent/WO2007015931A2/en
Publication of JP2009502922A publication Critical patent/JP2009502922A/ja
Publication of JP2009502922A5 publication Critical patent/JP2009502922A5/ja
Pending legal-status Critical Current

Links

JP2008523976A 2005-07-28 2006-07-20 カスパーゼ阻害剤プロドラッグ Pending JP2009502922A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70337505P 2005-07-28 2005-07-28
PCT/US2006/028174 WO2007015931A2 (en) 2005-07-28 2006-07-20 Caspase inhibitor prodrugs

Publications (2)

Publication Number Publication Date
JP2009502922A JP2009502922A (ja) 2009-01-29
JP2009502922A5 true JP2009502922A5 (cg-RX-API-DMAC7.html) 2009-09-03

Family

ID=37709070

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008523976A Pending JP2009502922A (ja) 2005-07-28 2006-07-20 カスパーゼ阻害剤プロドラッグ

Country Status (14)

Country Link
US (2) US7879891B2 (cg-RX-API-DMAC7.html)
EP (1) EP1910379B1 (cg-RX-API-DMAC7.html)
JP (1) JP2009502922A (cg-RX-API-DMAC7.html)
KR (1) KR20080038369A (cg-RX-API-DMAC7.html)
CN (1) CN101268084A (cg-RX-API-DMAC7.html)
AT (1) ATE529430T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006276096A1 (cg-RX-API-DMAC7.html)
CA (1) CA2616337A1 (cg-RX-API-DMAC7.html)
IL (1) IL188997A0 (cg-RX-API-DMAC7.html)
NO (1) NO20081050L (cg-RX-API-DMAC7.html)
NZ (1) NZ566022A (cg-RX-API-DMAC7.html)
RU (1) RU2427582C2 (cg-RX-API-DMAC7.html)
WO (1) WO2007015931A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200801172B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050159A1 (es) 2003-05-27 2005-04-19 Vertex Pharma Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa
PL217743B1 (pl) * 2004-05-15 2014-08-29 Vertex Pharma Zastosowanie inhibitorów ICE/kaspazy-1 do leczenia napadów i konwulsji w epilepsji oraz zawierające je kompozycja farmaceutyczna i zestaw
WO2006057961A1 (en) * 2004-11-24 2006-06-01 Vertex Pharmaceuticals Incorporated 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
JP5249770B2 (ja) 2005-11-03 2013-07-31 バーテックス ファーマシューティカルズ インコーポレイテッド キナーゼインヒビターとして有用なアミノピリジン
KR20090099886A (ko) * 2008-03-18 2009-09-23 주식회사 엘지생명과학 캐스파제 저해제의 프로드럭
US8518942B2 (en) 2008-08-06 2013-08-27 Buck Institute For Research On Aging Caspase inhibitors and uses thereof
ES2423668T3 (es) * 2009-05-22 2013-09-23 Abbvie Inc. Moduladores de receptores 5-HT y métodos de uso de los mismos
RU2542988C2 (ru) * 2009-07-31 2015-02-27 Глоубал Элаенс Фор Тб Драг Дивелопмент Нитроимидазооксазины и их применения при противотуберкулезной терапии
NZ598165A (en) * 2009-07-31 2013-05-31 Global Alliance For Tb Drug Dev Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
WO2011146089A1 (en) * 2010-05-21 2011-11-24 Abbott Laboratories Modulators of 5-ht receptors and methods of use thereof
CN101979403A (zh) * 2010-09-13 2011-02-23 沈陵陵 新型半胱氨酸天冬氨酸广谱蛋白酶抑制剂及其制备方法和用途
US9956260B1 (en) 2011-07-22 2018-05-01 The J. David Gladstone Institutes Treatment of HIV-1 infection and AIDS
CN107793434B (zh) * 2016-09-07 2022-05-24 帝斯曼知识产权资产管理有限公司 用于制备经取代的咪唑并噻唑酮的方法
KR102437095B1 (ko) * 2019-04-19 2022-08-26 주식회사 엘지화학 캐스파제 저해제의 프로드럭
CN113767097B (zh) 2019-04-30 2025-03-14 株式会社Lg化学 半胱天冬酶抑制剂的前药
US12257341B2 (en) 2019-05-31 2025-03-25 Lg Chem, Ltd. Injectable composition containing prodrug of caspase inhibitors, and preparation method therefor
US20220226306A1 (en) 2019-05-31 2022-07-21 Lg Chem, Ltd. Composition for caspase inhibitor prodrug injection
KR102670554B1 (ko) 2022-01-04 2024-05-30 주식회사 이노보테라퓨틱스 캐스파제 저해제로서의 신규한 이소인돌리논 유도체 화합물
WO2025221068A1 (ko) * 2024-04-19 2025-10-23 (주)노보메디슨 심장질환의 예방 또는 치료를 위한 캐스파제 저해제

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874424A (en) 1995-12-20 1999-02-23 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
SU1441748A1 (ru) * 1987-03-04 1995-09-10 Пермский государственный университет 3-(4-бромфенил)-3а,4,6,6а-тетрагидрофуро[3,4-d]изоксазол-4-он, проявляющий противовоспалительную активность
SU1586154A1 (ru) * 1988-09-15 2006-12-20 Краснодарский политехнический институт 3-(2,4-Дихлорфенил)-4-оксо-3a,4,6,6a-тетрагидрофуро-[3,4-d]изоксазол, проявляющий антигельминтную и анальгетическую активность
US5716929A (en) 1994-06-17 1998-02-10 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US5847135A (en) 1994-06-17 1998-12-08 Vertex Pharmaceuticals, Incorporated Inhibitors of interleukin-1β converting enzyme
US5756466A (en) 1994-06-17 1998-05-26 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
NZ291508A (en) * 1994-08-30 1999-07-29 Sankyo Co Isoxazoles; preparation and medicaments
US5672584A (en) * 1995-04-25 1997-09-30 The University Of Kansas Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
US5843904A (en) 1995-12-20 1998-12-01 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1βconverting enzyme
JP2000501428A (ja) 1996-09-12 2000-02-08 アイドゥン ファーマシューティカルズ,インコーポレイテッド 酵素のice/ced−3プロテアーゼファミリーを阻害する新規な三環式化合物
JP3492703B2 (ja) 1996-09-12 2004-02-03 アイドゥン ファーマシューティカルズ,インコーポレイテッド システインプロテアーゼのICE/ced―3ファミリーの阻害剤としてのC―末端変性(N―置換)―2―インドリルジペプチド
ATE310528T1 (de) 1996-09-12 2005-12-15 Idun Pharmaceuticals Inc Hemmung der apoptose unter verwendung von inhibitoren der interleukin-1 beta converting enzym (ice)/ced-3 familie
US5968927A (en) 1996-09-20 1999-10-19 Idun Pharmaceuticals, Inc. Tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes
US5919790A (en) 1996-10-11 1999-07-06 Warner-Lambert Company Hydroxamate inhibitors of interleukin-1β converting enzyme
CA2268098A1 (en) 1996-10-11 1998-04-23 Warner-Lambert Company Aspartate ester inhibitors of interleukin-1.beta. converting enzyme
US6184244B1 (en) 1996-12-16 2001-02-06 Idun Pharmaceuticals, Inc. C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
US6184210B1 (en) 1997-10-10 2001-02-06 Cytovia, Inc. Dipeptide apoptosis inhibitors and the use thereof
DK1049703T3 (da) 1998-01-20 2003-06-02 Abbott Gmbh & Co Kg N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2--(4-fluorphenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-L-asparaginsyrealdehyd som en in vivo inhibitor af interleukin-1beta konverterende enzym
JP4499917B2 (ja) 1998-03-09 2010-07-14 バーテックス ファーマシューティカルズ インコーポレイテッド インターロイキン−1β変換酵素のインヒビターとしての1,2−ジアゼパン誘導体
PL204619B1 (pl) * 1998-03-19 2010-01-29 Vertex Pharma Pochodna peptydowa, kompozycja farmaceutyczna zawierająca taką pochodną i zastosowanie pochodnej peptydowej
US6197750B1 (en) 1998-07-02 2001-03-06 Idun Pharmaceuticals, Inc. C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
US6242422B1 (en) 1998-10-22 2001-06-05 Idun Pharmacueticals, Inc. (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
ATE344249T1 (de) 1999-07-19 2006-11-15 Merck Frosst Canada Ltd Pyrazinone, diese verbindungen enthaltende zusammenstellungen
PT1163208E (pt) 1999-08-06 2004-08-31 Vertex Pharma Inibidores de caspase e as suas utilizacoes
AR026748A1 (es) * 1999-12-08 2003-02-26 Vertex Pharma Un compuesto inhibidor de caspasas, una composicion farmaceutica que lo comprende, un metodo para la sintesis del mismo y un compuesto intermediario paradicha sintesis
US6689784B2 (en) * 2000-03-29 2004-02-10 Vertex Pharmaceuticals Incorporated Carbamate caspase inhibitors and uses thereof
ATE472539T1 (de) 2000-04-24 2010-07-15 Vertex Pharma Verfahren und zwischenprodukte zur herstellung von substituierten asparaginsäure-acetalen
PE20011350A1 (es) * 2000-05-19 2002-01-15 Vertex Pharma PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
NZ516918A (en) 2000-05-23 2004-06-25 Vertex Pharma Caspase inhibitors and uses thereof
DE60131160T2 (de) 2000-06-07 2008-08-07 Vertex Pharmaceuticals Inc., Cambridge Caspase-inhibitoren und ihre verwendungen
JP2004509120A (ja) 2000-09-13 2004-03-25 バーテックス ファーマシューティカルズ インコーポレイテッド カスパーゼ阻害剤およびそれらの用途
EP1341767B1 (en) 2000-11-21 2007-04-11 Vertex Pharmaceuticals Incorporated Imidazole and benzimidazole caspase inhibitors and uses thereof
MXPA03009647A (es) 2001-04-19 2004-01-29 Vertex Pharma Heterociclildicarbamidas como inhibidores de caspasa.
CA2447999C (en) 2001-05-23 2011-04-26 Vertex Pharmaceuticals Incorporated Caspase inhibitors and uses thereof
PE20040728A1 (es) * 2002-06-28 2004-10-23 Vertex Pharma Inhibidores de caspasa
PE20050159A1 (es) * 2003-05-27 2005-04-19 Vertex Pharma Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa

Similar Documents

Publication Publication Date Title
CA3081790C (en) Macrocyclic compounds as trk kinase inhibitors and uses thereof
RU2008107576A (ru) Пролекарства ингибитора каспазы
TW202309025A (zh) Parp1抑制劑及其用途
JP2003535865A5 (cg-RX-API-DMAC7.html)
CA2856886C (fr) Nouveaux derives phosphates, leur utilisation en cancerologie, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2019070059A1 (ja) 置換された多環性ピリドン誘導体の立体選択的な製造方法
CA3174837A1 (en) Pyrazolo[1,5-d][1,2,4]triazine-5(4h)-acetamides as inhibitors of the nlrp3 inflammasome pathway
TW202425982A (zh) 泛素特異性蛋白酶1的抑制劑及其應用
KR102519536B1 (ko) 트리시클릭 회전장애이성질체 화합물
TW202400596A (zh) 三環parp1抑制劑及其用途
JP2005505618A5 (cg-RX-API-DMAC7.html)
JP2005533825A5 (cg-RX-API-DMAC7.html)
EP3024833A1 (fr) Nouveaux dérivés d'indolizine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CA2447999A1 (en) Caspase inhibitors and uses thereof
JP6513075B2 (ja) オートタキシン阻害活性を有する縮合ピラゾール誘導体
JP2006513220A5 (cg-RX-API-DMAC7.html)
PT1666477E (pt) Derivado de 7-(4-substituído-3-ciclopropilaminometil-1- pirrolidinil) quinolonecarboxílico
JP2024523646A (ja) 5-オキソ-ピリド[2,3-d]ピリダジン-6(5H)-イルアセトアミド
JP2022549345A (ja) マイコバクテリア感染症の処置のためのアザインドールカルボキサミド化合物
EP2757883A1 (en) Triazolopyridyl compounds as aldosterone synthase inhibitors
ES2286408T3 (es) Sales de alquilamonio de omeprazol e esomeprazol.
RU2709810C2 (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛО[3,4-с]ПИРИДИНА
WO2024114704A1 (zh) 新型irak4抑制剂以及抑制并降解irak4蛋白的化合物及其制备方法和应用
JPS58172391A (ja) 1H−ピラゾロ〔1,5−a〕ピリミジンの置換エテニル誘導体
MX2008001360A (en) Caspase inhibitor prodrugs